Azmi Nabulsi - 11 Apr 2023 Form 4 Insider Report for Phathom Pharmaceuticals, Inc. (PHAT)

Role: Chief Operating Officer
Signature: /s/ Larry Miller, Attorney-in-Fact for Azmi Nabulsi
Issuer symbol: PHAT
Transactions as of: 11 Apr 2023
Transactions value $: $82,600
Form type: 4
Filing time: 11 Apr 2023, 16:05:07 UTC
Previous filing: 20 Jan 2023
Next filing: 17 Jul 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PHAT	Common Stock	Purchase	$82.6K	+10K	+11.16%	$8.26	99.6K	11 Apr 2023	Direct	F1
holding	PHAT	Common Stock						2.36K	11 Apr 2023	by 401(k)
holding	PHAT	Common Stock						786K	11 Apr 2023	by Trust

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.20 to $8.50. The Reporting Person undertakes to provide Phathom Pharmaceuticals, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.20 to $8.50. The Reporting Person undertakes to provide Phathom Pharmaceuticals, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.